Marisa Lin Wong Medina

Title: Marisa Lin Wong Medina: Innovator in Cholesterol Modulation

Introduction

Marisa Lin Wong Medina is a prominent inventor based in Hercules, California. She has made significant contributions to the field of cholesterol modulation through her innovative research and patent.

Latest Patents

Marisa holds a patent titled "HMGCR isoforms in prediction of efficacy and identification of cholesterol-modulating compounds." This invention provides methods for assessing a subject's responsiveness to HMGCR inhibitor therapy. It also includes the selection of a suitable HMGCR inhibitor therapy based on these assessments. Furthermore, the invention outlines methods for identifying agents that modulate HMGCR activity, particularly through the modulation of HMGCR mRNA splicing, while avoiding the elevation of the statin-resistant isoform of HMGCR. She has 1 patent to her name.

Career Highlights

Marisa is affiliated with the Children's Hospital & Research Center Oakland, where she continues her research and development in the medical field. Her work focuses on improving therapeutic strategies for cholesterol management.

Collaborations

One of her notable collaborators is Ronald M Krauss, with whom she has worked on various projects related to cholesterol modulation and its implications for health.

Conclusion

Marisa Lin Wong Medina's innovative work in cholesterol modulation has the potential to significantly impact therapeutic approaches in medicine. Her contributions are paving the way for advancements in the understanding and treatment of cholesterol-related conditions.